Bristol-Myers Squibb appoints Giovanni Caforio as chairman
Mr. Caforio has been chief executive officer of Bristol-Myers Squibb since May 2015 and has been serving on the company’s Board of Directors since June 2014.
Prior to becoming CEO, Mr. Caforio served as chief operating officer with responsibility for leading a fully integrated worldwide commercial organization and the companywide functions of Enterprise Services and Global Manufacturing & Supply.
This was preceded by his work as the company’s chief commercial officer.
Mr. Caforio received his M.D. from the University of Rome.
Mr. Caforio, who will continue to serve as chief executive officer, will succeed current Chairman Lamberto Andreotti, who has announced his plan to retire.
Mr. Andreotti served as Bristol-Myers Squibb’s chief executive officer from 2010 through May 2015 and will have served as Bristol-Myers Squibb’s chairman for two years when Caforio’s appointment becomes effective in May 2017. ■
What to read next
LATEST MOVES FROM New York
- Jim Gianopulos named chairman and CEO of Paramount Pictures
- Acuamark Diagnostics adds Michael Hanbury to board
- Gibraltar Industries appoints Timothy Murphy as CFO
- Wecast Network appoints Simon Wang as CFO
- Sequential Brands Group appoints Karen Murray as CEO
More inside POST
HSBC Holdings Q4 loss $4.44 billion Earnings
Forget today, work for tomorrow Leadership
Why CEOs delay sharing bad news Leadership